One Plus One Wealth Management LLC Has $757,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

One Plus One Wealth Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,295 shares of the healthcare conglomerate’s stock after buying an additional 35 shares during the quarter. One Plus One Wealth Management LLC’s holdings in UnitedHealth Group were worth $757,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tealwood Asset Management Inc. acquired a new position in shares of UnitedHealth Group during the third quarter worth $2,905,000. Asset Planning Services Inc. LA ADV lifted its stake in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares during the period. Sequoia Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares during the period. Americana Partners LLC raised its stake in UnitedHealth Group by 10.8% during the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares during the last quarter. Finally, Concord Investment Counsel Inc. acquired a new stake in UnitedHealth Group during the 1st quarter worth about $14,544,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $566.96 on Wednesday. The stock has a fifty day moving average of $580.96 and a 200 day moving average of $543.36. The firm has a market capitalization of $523.54 billion, a price-to-earnings ratio of 36.94, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the company posted $6.56 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.48%. UnitedHealth Group’s payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Robert W. Baird raised their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Barclays reduced their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

View Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).